Pharmarise Holdings Corp. Financial Overview
Pharmarise Holdings Corp.'s market cap is currently ¥6.09B. The company's EPS TTM is ¥-1.62; its P/E ratio is -23.21; and it has a dividend yield of 2.70%. Pharmarise Holdings Corp. is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
